Melphalan - Wikipedia

Melphalan (trade name Alkeran, in former USSR also known as Sarcolysin) is a chemotherapy drug belonging to the class of nitrogen mustard alkylating agents.

Melphalan - Chemotherapy Drugs - Chemocare

Melphalan (Alkeran) chemotherapy side effects, how it's given, how it works, precautions and self care tips for treatment of multiple cancers

Alkeran, Evomela (melphalan) dosing, indications ...

Medscape - Multiple Myeloma dosing for Alkeran, Evomela (melphalan), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

Melphalan - FDA prescribing information, side effects and uses

Melphalan official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

ALKERAN - Melphalan - Posologie, Effets secondaires ...

La posologie dépend du protocole thérapeutique appliqué au malade et tient compte de l'indication et des éventuelles thérapeutiques associées.

Daratumumab plus Bortezomib, Melphalan, and Prednisone for ...

n engl j med 378;6 nejm.orgFebruary 8, 2018 519 Daratumumab for Untreated Myeloma T he risk of multiple myeloma in-creases with age,1-3 and despite progress

Bortezomib plus Melphalan and Prednisone for Initial ...

original article The new england journal of medicine 906 n engl j med 359;9 www.nejm.org august 28, 2008 Bortezomib plus Melphalan and Prednisone

Melphalan - Oncoprof - Page d'accueil

Le melphalan (Alkéran™) est un agent alkylant bifonctionnel. Par ses deux groupement alkylés, il établit des liaisons covalentes stables avec les groupements ...

EVOMELA® (melphalan for injection)

In multiple myeloma, a high-dose conditioning treatment prior to stem cell transplant

Melphalan 2 mg Tablets - Summary of Product ...

Since Melphalan is myelosuppressive, frequent blood counts are essential during therapy and the dosage should be delayed or adjusted if necessary (see Special ...